A novel mutation in EROS (CYBC1) causes chronic granulomatous disease

A novel mutation in EROS (CYBC1) causes chronic granulomatous disease

Copyright © 2023. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 255(2023) vom: 01. Okt., Seite 109761
1. Verfasser: Mortimer, Paige M (VerfasserIn)
Weitere Verfasser: Nichols, Esme, Thomas, Joe, Shanbhag, Rachna, Singh, Neha, Coomber, Eve L, Malik, Talat H, Pickering, Matthew C, Randzavola, Lyra, Rae, William, Bhattad, Sagar, Thomas, David C
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't CYBC1 Chronic granulomatous disease EROS NADPH Oxidases EC 1.6.3.- Reactive Oxygen Species
LEADER 01000naa a22002652 4500
001 NLM361708734
003 DE-627
005 20231226085719.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2023.109761  |2 doi 
028 5 2 |a pubmed24n1205.xml 
035 |a (DE-627)NLM361708734 
035 |a (NLM)37673227 
035 |a (PII)S1521-6616(23)00524-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Mortimer, Paige M  |e verfasserin  |4 aut 
245 1 2 |a A novel mutation in EROS (CYBC1) causes chronic granulomatous disease 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 02.10.2023 
500 |a Date Revised 02.10.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2023. Published by Elsevier Inc. 
520 |a Chronic Granulomatous Disease (CGD) is an inborn error of immunity characterised by opportunistic infection and sterile granulomatous inflammation. CGD is caused by a failure of reactive oxygen species (ROS) production by the phagocyte NADPH oxidase. Mutations in the genes encoding phagocyte NADPH oxidase subunits cause CGD. We and others have described a novel form of CGD (CGD5) secondary to lack of EROS (CYBC1), a highly selective chaperone for gp91phox. EROS-deficient cells express minimal levels of gp91phox and its binding partner p22phox, but EROS also controls the expression of other proteins such as P2X7. The full nature of CGD5 is currently unknown. We describe a homozygous frameshift mutation in CYBC1 leading to CGD. Individuals who are heterozygous for this mutation are found in South Asian populations (allele frequency = 0.00006545), thus it is not a private mutation. Therefore, it is likely to be the underlying cause of other cases of CGD 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a CYBC1 
650 4 |a Chronic granulomatous disease 
650 4 |a EROS 
650 7 |a NADPH Oxidases  |2 NLM 
650 7 |a EC 1.6.3.-  |2 NLM 
650 7 |a Reactive Oxygen Species  |2 NLM 
700 1 |a Nichols, Esme  |e verfasserin  |4 aut 
700 1 |a Thomas, Joe  |e verfasserin  |4 aut 
700 1 |a Shanbhag, Rachna  |e verfasserin  |4 aut 
700 1 |a Singh, Neha  |e verfasserin  |4 aut 
700 1 |a Coomber, Eve L  |e verfasserin  |4 aut 
700 1 |a Malik, Talat H  |e verfasserin  |4 aut 
700 1 |a Pickering, Matthew C  |e verfasserin  |4 aut 
700 1 |a Randzavola, Lyra  |e verfasserin  |4 aut 
700 1 |a Rae, William  |e verfasserin  |4 aut 
700 1 |a Bhattad, Sagar  |e verfasserin  |4 aut 
700 1 |a Thomas, David C  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 255(2023) vom: 01. Okt., Seite 109761  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:255  |g year:2023  |g day:01  |g month:10  |g pages:109761 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2023.109761  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 255  |j 2023  |b 01  |c 10  |h 109761